Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.6479
+0.0480 (8.00%)
At close: Aug 17, 2026
Cell Source Market Cap
Cell Source has a market cap or net worth of $44.02 million as of August 18, 2026. Its market cap has increased by 156.90% in one year.
Market Cap
44.02M
Enterprise Value
54.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.65
ChartMarket Cap Chart
Since July 1, 2014, Cell Source's market cap has increased from 36.03M to 44.02M, an increase of 22.18%. That is a compound annual growth rate of 1.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 44.02M | 80.34% |
| Dec 31, 2025 | 24.41M | 59.96% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 88.99M |
| Sangamo Therapeutics | 72.50M |
| Arch Biopartners | 56.03M |
| Vicapsys Life Sciences | 46.94M |
| Biomind Labs | 46.54M |
| Nuo Therapeutics | 37.27M |
| ProText Mobility | 34.29M |
| BetterLife Pharma | 32.91M |